Highest-materiality recent filing
Teleflex launches $250M accelerated share repurchase with Truist Bank
ASR with Truist Bank to repurchase $250M of common stock under existing $1B buyback program.
Teleflex Q2 revenue up 4.7% pro forma; cuts revenue guidance, raises adjusted EPS outlook
Q2 revenue $570.3M (+28.9% reported, +4.7% pro forma adj. constant currency); GAAP EPS $0.96, adj. EPS $1.76.
Teleflex completes $1.5B sale of OEM business; pro forma shows debt reduction and improved income
Net cash proceeds of $1.5B ($1.2B after-tax) from OEM business divestiture closed Aug 3, 2026.
Teleflex completes $1.5B sale of OEM business; plans debt paydown and share buybacks
Sale closed Aug 3, 2026 for $1.5B cash to Montagu and Kohlberg.
Teleflex announces $500M senior notes offering to refinance 2027 notes
Teleflex commenced offering of $500M senior notes due 2032; proceeds plus cash to redeem all $500M of 4.625% notes due 2027.
Teleflex enters $2.2B new credit facilities; $1B revolver and $1.2B term loans
Entered new $1B revolver, $500M term A-1, and $700M term A-2 credit facilities; refinances prior credit agreement.
Teleflex Q1 revenue up 5.1% pro forma; GAAP EPS $(0.11); maintains FY26 guidance
Revenue from continuing ops $548.3M, up 32.3% reported, +5.1% pro forma adjusted constant currency.
Teleflex appoints Jason Weidman as President and CEO effective June 8, 2026
Weidman succeeds interim CEO Stuart Randle, who remains on the board; Weidman to join board on start date.
Sale transactions of Acute Care, Interventional Urology, and OEM on track for H2 2026 close.
Teleflex updates on OEM and Acute Care divestitures; FTC Second Request for urology deal
OEM HSR waiting period expired March 13, 2026; closing anticipated in Q3 2026.
GAAP revenue from continuing ops $1,992.7M (+17.2% YoY); adjusted revenue $1,983.7M (+16.3%).
Teleflex CEO Liam Kelly out, interim CEO Stuart Randle appointed; 2025 revenue guide cut
Liam Kelly departs as President and CEO effective Jan 7, 2026; Stuart Randle appointed interim CEO.
Total cash consideration $2.03B: OEM business to Montagu/Kohlberg for $1.5B; Acute Care and Interventional Urology to Intersurgical for $530M.
Teleflex Reports Q3 2025 Revenue Growth but GAAP Loss; Lowers Full-Year Guidance
GAAP revenue $913.0M up 19.4% YoY; adjusted revenue $892.9M up 16.8% (adjusted constant currency up 15.3%).
Teleflex Q2 adj. EPS $3.73 beats $3.42 YoY; raises FY outlook on BIOTRONIK deal
GAAP revenue $780.9M (+4.2% YoY); adjusted constant currency revenue growth +1.0%.
Amendment to Credit Agreement added $200M in delayed draw term loans, bringing total commitments to $700M.
Q1 revenue $700.7M (-5.0% reported, -3.8% adj constant currency); GAAP EPS $2.07, adjusted EPS $2.91 (down from $3.21).
Teleflex reports Q4 adj EPS $3.89 (+15%); plans two-company split and BIOTRONIK acquisition
Q4 GAAP EPS from cont. ops. $(2.95) vs $0.66; adj EPS $3.89 vs $3.38 (+15.1%). Full-year adj EPS $14.01.
Teleflex Q3 GAAP EPS $2.36, adj $3.49; cuts FY revenue growth guidance to 2.9-3.4%
Q3 GAAP revenue $764.4M, +2.4% YoY; GAAP diluted EPS $2.36 vs $2.91; adjusted diluted EPS $3.49 vs $3.64.
Paid $200M to Bank of America on Aug 5, 2024, for initial delivery of shares valued at 80% of repurchase price based on Aug 1 closing price.
Teleflex Q2 adjusted revenue $763.5M (+2.7%); raises FY adj EPS guidance to $13.80-$14.20
GAAP revenue $749.7M (+0.9% YoY); adjusted revenue $763.5M (+2.7% YoY, +3.4% constant currency).
Teleflex Q1 revenue $737.8M (+3.8% YoY); adjusted EPS $3.21 vs $3.09; raises FY adjusted EPS low end
GAAP diluted EPS from continuing ops $0.33 vs $1.63 prior year, reflecting $1.69 pension settlement charge.
Teleflex Reports Q4 2023 Revenue of $773.9M, Full Year Revenue $2,974.5M; Provides 2024 Guidance
Q4 GAAP diluted EPS from continuing operations was $0.66, down from $1.65 in prior year; adjusted EPS was $3.38 vs $3.52.
Teleflex Reports Q3 2023 Revenue of $746.4M, Up 8.7%, Raises Full Year Guidance
Third quarter revenue $746.4M, up 8.7% reported and 7.4% constant currency year-over-year.
Teleflex Q2 revenue up 5.9% constant currency; revenue guidance raised, adjusted EPS maintained
Q2 revenues $743.3M, +5.9% constant currency YoY; GAAP diluted EPS $2.35, adjusted diluted EPS $3.41.
Revenue $710.9M, up 10.8% reported (+13.2% constant currency); growth across all global product categories.
Teleflex Q4 2022 revenue $758M, adjusted EPS $3.52; guides 2023 adjusted EPS $13.00-$13.60
Q4 revenue $758.0M (-0.5% reported, +3.7% constant currency); GAAP EPS $1.65, adjusted EPS $3.52.
Teleflex Q3 revenue down 1.9% YoY; cuts FY 2022 GAAP & adjusted EPS guidance
Q3 revenue $686.8M (-1.9% reported; +2.4% constant currency); GAAP EPS $2.16 vs $4.20 prior.
Revenue $704.5M, down 1.3% YoY; constant currency growth +2.3%.
Reaffirmed 2022 GAAP revenue growth of 2.3%-3.8% (4.0%-5.5% constant currency) and GAAP EPS $8.85-$9.45; adjusted EPS $13.70-$14.30.
Teleflex Q4 revenue $761.9M (+7.1%), adj. EPS $3.60 (+10.8%); 2022 adj. EPS guidance $13.70-$14.30
Q4 reported revenues $761.9M, up 7.1% YoY; constant currency growth 7.9%.
On April 30, 2026, Teleflex Incorporated (the “Company”) announced the appointment of Jason Weidman as the Company’s President and Chief Executive Officer, effective as of June 8, 2026 (the “Start Date”), replacing interim President and Chief Executive Officer Stuart A. Randle at that time.
On April 30, 2026, Teleflex Incorporated (the “Company”) announced the appointment of Jason Weidman as the Company’s President and Chief Executive Officer, effective as of June 8, 2026 (the “Start Date”), replacing interim President and Chief Executive Officer Stuart A. Randle at that time.
who on February 24, 2025 informed the Company that he will retire as Executive Vice President and Chief Financial Officer of the Company, effective April 1, 2025.
the Company’s Board of Directors appointed John R. Deren, 57, who has served as the Company’s Corporate Vice President and Chief Accounting Officer since May 2017, to serve as Executive Vice President and Chief Financial Officer of the Company, effective April 2, 2025.
On February 21, 2022, Richard A. Packer notified the Board of Directors (the "Board") of Teleflex Incorporated ("Teleflex" or the "Company") that he will not stand for reelection to the Board at the Company's 2022 annual meeting of stockholders (the "2022 Annual Meeting") and will retire as a member of the Board, effective immediately prior to the 2022 Annual Meeting.
Max materiality 0.90 · Median 0.62 · Most common event earnings